BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2009
View Archived Issues
New data on saxagliptin, preregistered for type 2 diabetes, released at ADA congress
Read More
ASCO snapshots: data from phase II trials of potential treatments for lung cancer disclosed
Read More
Snapshots: potential new treatments for melanoma presented at ASCO
Read More
First phase III study of bupropion/naltrexone shows benefits besides weight loss in obesity
Read More
Novel glycogen phosphorylase inhibitor designed at GlaxoSmithKline
Read More
Afresa data show efficacy and pulmonary function safety in diabetes patients
Read More
Jazz Pharmaceuticals puts three drugs on hold, will continue development of sodium oxybate
Read More
Janssen launches its long-acting antipsychotic drug Risperdal Consta in Japan
Read More
Bionomics commences phase I trial of anxiety drug candidate, BNC-210
Read More
Addex initiates phase I trial for mGluR positive allosteric modulator ADX-71149
Read More
Orchid Chemicals & Pharmaceuticals discovers pSTAT3/IL-6 inhibitors for cancer therapy
Read More
Neuraxon presents dual nNOS and NE reuptake inhibitors as analgesics
Read More
Nucynta immediate-release tablets launched in the U.S. for acute pain
Read More
Oxigene commences phase II Zybrestat trial for ophthalmology
Read More
Cytos reports biochemical findings from phase IIa hypertension vaccine trial
Read More
Osiris reports phase II clinical trial results of Prochymal in COPD
Read More
E.U. approves Novartis' once-yearly Aclasta for steroid-induced osteoporosis
Read More
CHMP issues positive opinion regarding BMS and AstraZeneca's MAA for Onglyza
Read More
Phase I study reveals tolerability, gene expression changes with ABR-215757 in SLE
Read More
Effect of RDEA-594 on renal transporters evaluated
Read More
Pasireotide snapshots: Recent preclinical and clinical studies
Read More
Boehringer receives positive recommendation from the EMEA for Mirapexin
Read More
FDA issues preliminary review letter regarding Acura Pharmaceuticals' NDA for Acurox
Read More
Cerulean signs worldwide license agreement with Arrowhead for Cyclosert and IT-101
Read More
European CHMP recommends marketing authorization for UCB's Cimzia in RA
Read More